T +27 21 526 2800 | F +27 21 526 2801

TUNISIA

View All News

Patent Information

International and Regional Arrangements:

  • Paris Convention:  Yes
  • PCT:  Yes (national phase deadline is 30 months from the priority date)
  • ARIPO:  No
  • OAPI:  No

Filing Requirements:

  • Published PCT application or specification, abstract and drawings if non-PCT (required on the day of filing)
  • Power of Attorney, simply signed (can be filed within 2 months)
  • Assignment of Invention, simply signed (if not filed during international phase)
  • English, French or Arabic translation of specification, claims and abstract if the PCT application was filed in another language (can be filed within 3 months)
  • International Search Report and International Preliminary Examination Report (no set deadline)
  • Certified priority document (if not lodged in the international phase) – can be filed within 3 months

Novelty:   Absolute novelty is required

Patentability:   Methods of medical treatment, surgery or diagnosis are not patentable

Excess Fees:   Excess fees are incurred for more than 10 claims, payable at the time of filing

Examination:   As to form only

Term of Patent:   20 years from the effective filing date

Renewals:   Payable annually in advance from the first anniversary of the effective filing date

General Information

  • Area: Approximately 163 600 km2
  • Population: 10.6 million
  • Capital: Tunis
  • Currency: Tunisian Dinar
  • GDP:  $ 100.3 billion (2010)
  • Domain name extension: .tn
  • Languages: Arabic (official language), French
  • Exports: Agricultural products; chemicals and phosphates; electrical equipment; mechanical goods; semi-finished goods, textiles and clothing
  • Imports:  Hydrocarbons; food; textiles; machinery and equipment; chemicals

International / Regional Conventions:

  • Berne Convention
  • Hague Agreement on Designs
  • Nice Agreement on Classification of Marks
  • Paris Convention
  • Patent Cooperation Treaty
  • WIPO Convention
  • WTO/TRIPS
Share this...
Tweet about this on TwitterShare on FacebookShare on LinkedIn